Estradiol Valerate And Estradiol Valerate/dienogest Kit
Product Images NDC 0781-4110

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Estradiol Valerate And Estradiol Valerate/dienogest (NDC 0781-4110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ev Chem Struc (Image 01)

Chemical structure diagram of estradiol valerate, depicting its steroidal backbone with characteristic functional groups including a valeryl ester attached at the C17 position and a hydroxyl group on the aromatic ring.*

FDA Label Image

Dien Chem Struc (Image 02)

Chemical structure of estradiol valerate, the active ingredient in the product Estradiol Valerate and Estradiol Valerate/Dienogest by Sandoz Inc. The diagram shows a steroid backbone with specific hydroxyl and cyano functional groups.*

FDA Label Image

Fig 1 (Image 03)

A line graph titled 'Median of MBL Volume by Cycle - Data from Study 308960' comparing median menstrual blood loss volume (mL) over seven cycles between Estradiol Valerate and Estradiol Valerate/Dienogest versus placebo groups. The Estradiol Valerate and Estradiol Valerate/Dienogest line shows a marked decrease in median MBL volume over cycles, while placebo remains relatively steady.*

FDA Label Image

Fig 2 (Image 04)

Line graph showing median menstrual blood loss (MBL) volume by cycle days for Estradiol Valerate and Estradiol Valerate/Dienogest versus placebo. The median MBL for Estradiol Valerate and Estradiol Valerate/Dienogest decreases sharply after Cycle 1 and remains low through Cycle 7, while placebo shows consistently higher MBL volumes over the same cycles.*

FDA Label Image

Birth Control Chart (Image 05)

A chart comparing birth control methods by their pregnancy rates per 100 women in one year. Methods with fewer pregnancies include implants, injections, intrauterine devices, and sterilization. Birth control pills, skin patches, and vaginal rings fall in the mid-range. Condoms and diaphragms show higher pregnancy rates, while no sex during fertile days, spermicides, and withdrawal show even higher rates. No birth control is associated with the highest pregnancy rate.*

FDA Label Image

Blister Pack (Image 06)

An instructional diagram showing a 28-tablet oral contraceptive kit with tablets arranged in four rows. The image directs to start taking pills from left to right, specifying different tablet colors and their positions: dark yellow tablets in positions 1-2, medium red tablets in positions 3-7, light yellow tablets in positions 8-24, dark red tablets in positions 25-26, and white inert tablets in positions 27-28.*

FDA Label Image

Single Carton (Image 07)

Packaging label for Estradiol Valerate and Estradiol Valerate/Dienogest oral tablets kit by Sandoz Inc. The kit includes Estradiol Valerate Tablets 3 mg and 1 mg, and Estradiol Valerate/Dienogest Tablets in dosages 2 mg/2 mg, 2 mg/3 mg. The package contains 28 oral tablets. The label includes prescription-only status and a warning that the product does not protect against HIV or other sexually transmitted diseases.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.